pharma news today obesity drugs glp-1 today Agonists Weight Loss Market Report, 2025-2030 Nutritional priorities to support GLP-1

2024;36(6):1302-19.e12

Efficacy and safety of once-weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: A 52-week open-label, randomized phase III trial

And for those using BPC-157 or TB-500 for recovery alongside their GLP-1 therapy, the BPC-157 and TB-500 stacking guide along with the BPC-157 versus TB-500 comparison provides detailed guidance on combining these compounds safely

doi: 10.1056/NEJMe2312646 [DOI] [PubMed] [Google Scholar] 266

They target the body and mind simultaneously, helping to reduce a primary cause of weight gain: a strong appetite that leads to overeating